TW200738239A - Stable solid formulation of sertindole - Google Patents

Stable solid formulation of sertindole

Info

Publication number: TW200738239A
Authority: TW; Taiwan
Prior art keywords: sertindole; solid formulation; stable solid; pharmaceutical composition; relates
Prior art date: 2005-09-08

Application number

TW095130202A

Other languages

English (en)

Inventor

Flemming Enok Olsen

Anne Ravnholdt Christensen

Ken Liljegren

Original Assignee

Lundbeck & Co As H

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2005-09-08

Filing date

2006-08-17

Publication date

2007-10-16

2006-08-17 Application filed by Lundbeck & Co As H filed Critical Lundbeck & Co As H

2007-10-16 Publication of TW200738239A publication Critical patent/TW200738239A/zh

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2813—Inorganic compounds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/454—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. pimozide, domperidone
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
- A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Epidemiology (AREA)
General Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Inorganic Chemistry (AREA)
Psychiatry (AREA)
Medicinal Preparation (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

TW095130202A 2005-09-08 2006-08-17 Stable solid formulation of sertindole TW200738239A (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
DKPA200501255		2005-09-08

Publications (1)

Publication Number	Publication Date
TW200738239A true TW200738239A (en)	2007-10-16

Family

ID=37697999

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
TW095130202A TW200738239A (en)	2005-09-08	2006-08-17	Stable solid formulation of sertindole

Country Status (17)

Country	Link
EP (1)	EP1924261A1 (zh)
JP (1)	JP2009507051A (zh)
KR (1)	KR20080042102A (zh)
CN (1)	CN101257906A (zh)
AR (1)	AR056475A1 (zh)
AU (1)	AU2006322460A1 (zh)
BR (1)	BRPI0615630A2 (zh)
CA (1)	CA2621866A1 (zh)
EA (1)	EA013167B1 (zh)
IL (1)	IL189541A0 (zh)
MX (1)	MX2008002290A (zh)
NO (1)	NO20081721L (zh)
NZ (1)	NZ565330A (zh)
TW (1)	TW200738239A (zh)
UA (1)	UA97349C2 (zh)
WO (1)	WO2007065448A1 (zh)
ZA (1)	ZA200801169B (zh)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
TWI320783B (en)	2005-04-14	2010-02-21	Otsuka Pharma Co Ltd	Heterocyclic compound
CN106344533A (zh) *	2009-01-29	2017-01-25	大日本住友制药株式会社	具有内核的口腔崩解片剂
FR2943061B1 (fr) *	2009-03-13	2011-02-25	Rhodia Operations	Composes organophosphores, systemes catalytiques comprenant ces composes et procede d'hydrocyanation ou d'hydroformylation utilisant ces systemes catalytiques
US8883823B2 (en)	2012-07-16	2014-11-11	Fibrogen, Inc.	Crystalline forms of a prolyl hydroxylase inhibitor
KR20220164068A (ko)	2012-07-16	2022-12-12	피브로겐, 인크.	프롤릴 하이드록실라제 억제제 [(4-하이드록시-1-메틸-7-페녹시-아이소퀴놀린-3-카보닐)-아미노]-아세트산의 결정형
CN110448537A (zh) *	2013-06-06	2019-11-15	菲布罗根有限公司	Hif羟化酶抑制剂的药物制剂
EP3043793B1 (en) *	2013-11-19	2021-01-06	Siga Technologies Inc.	Rehydration of micronized tecovirimat monohydrate
JP2018172361A (ja) *	2016-10-14	2018-11-08	大原薬品工業株式会社	光安定性を改善した、デュロキセチンを含有する固形製剤

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JPH04346929A (ja) *	1991-05-22	1992-12-02	Takada Seiyaku Kk	光に安定なメシル酸ブロモクリプチン製剤
JP2000507544A (ja) *	1996-03-25	2000-06-20	イーライ・リリー・アンド・カンパニー	痛みの治療方法
ZA973433B (en) *	1996-04-24	1997-12-10	Shionogi & Co	A sertindole-containing preparation and a method for producing the same.
ZA977967B (en) *	1996-09-23	1999-03-04	Lilly Co Eli	Combination therapy for treatment of psychoses

2006
- 2006-06-09 UA UAA200803569A patent/UA97349C2/uk unknown
- 2006-08-17 TW TW095130202A patent/TW200738239A/zh unknown
- 2006-08-29 AR ARP060103764A patent/AR056475A1/es not_active Application Discontinuation
- 2006-09-06 JP JP2008529472A patent/JP2009507051A/ja not_active Withdrawn
- 2006-09-06 EA EA200800774A patent/EA013167B1/ru not_active IP Right Cessation
- 2006-09-06 KR KR1020087004910A patent/KR20080042102A/ko not_active Withdrawn
- 2006-09-06 CN CNA2006800323410A patent/CN101257906A/zh active Pending
- 2006-09-06 WO PCT/DK2006/050038 patent/WO2007065448A1/en active Application Filing
- 2006-09-06 CA CA002621866A patent/CA2621866A1/en not_active Abandoned
- 2006-09-06 ZA ZA200801169A patent/ZA200801169B/xx unknown
- 2006-09-06 MX MX2008002290A patent/MX2008002290A/es not_active Application Discontinuation
- 2006-09-06 EP EP06846966A patent/EP1924261A1/en not_active Withdrawn
- 2006-09-06 NZ NZ565330A patent/NZ565330A/en not_active IP Right Cessation
- 2006-09-06 BR BRPI0615630A patent/BRPI0615630A2/pt not_active IP Right Cessation
- 2006-09-06 AU AU2006322460A patent/AU2006322460A1/en not_active Abandoned
2008
- 2008-02-14 IL IL189541A patent/IL189541A0/en unknown
- 2008-04-08 NO NO20081721A patent/NO20081721L/no not_active Application Discontinuation

Also Published As

Publication number	Publication date
EP1924261A1 (en)	2008-05-28
KR20080042102A (ko)	2008-05-14
JP2009507051A (ja)	2009-02-19
EA013167B1 (ru)	2010-02-26
EA200800774A1 (ru)	2008-06-30
CN101257906A (zh)	2008-09-03
NO20081721L (no)	2008-04-08
CA2621866A1 (en)	2007-06-14
IL189541A0 (en)	2008-08-07
WO2007065448A1 (en)	2007-06-14
UA97349C2 (uk)	2012-02-10
AU2006322460A1 (en)	2007-06-14
NZ565330A (en)	2011-06-30
MX2008002290A (es)	2008-03-14
AR056475A1 (es)	2007-10-10
ZA200801169B (en)	2010-07-28
BRPI0615630A2 (pt)	2016-11-16

Similar Documents

Publication	Publication Date	Title
TW200738239A (en)	2007-10-16	Stable solid formulation of sertindole
WO2006107451A3 (en)	2006-11-30	Honokiol derivatives for the treatment of proliferative disorders
IL195030A (en)	2013-09-30	IV dpp inhibitor assemblies
CL2007003244A1 (es)	2008-04-04	Compuestos derivados de pirimido[5,4-d][2]benzazepina; composicion farmaceutica que comprende a dicho compuesto; y uso del compuesto para el tratamiento del cancer.
MX2008011085A (es)	2008-09-05	Composiciones antimicrobianas y metodos para sellar cateteres.
JP2006519866A5 (zh)	2007-03-22
WO2007098128A3 (en)	2007-10-11	Phenylephrine-containing liquid formulations
WO2008097640A3 (en)	2008-10-02	Triazole compounds that are useful in the treatment of proliferative disorders, such as cancer
CL2007002261A1 (es)	2008-05-02	Compuestos derivados de imidazo[1,2-b]piridazina, inhibidores de quinasa; composicion farmaceutica; y uso en el tratamiento o prevencion del cancer.
CL2008001024A1 (es)	2009-01-02	Compuestos derivados de ftalazinona; composicion farmaceutica que comprende a dicho compuesto; y uso del compuesto para el tratamiento de enfermedades cardiovasculares, parkinson, enfermedades inflamatorias, esclerosis multiple, cancer, entre otras
BRPI0806531A2 (pt)	2014-04-22	Composto, composição farmacêutica, agente terapêutico, e, uso do composto.
BRPI0814593A2 (pt)	2015-01-20	Composto, composição farmacêutica que o contém e uso do composto.
BRPI0809667A2 (pt)	2014-10-07	Composto, medicamento e composição farmacêutica que o contém e uso do composto
JO2578B1 (en)	2011-02-27	Compounds Theophene benzimidazole
CL2008003473A1 (es)	2009-08-14	Compuestos derivados de fenilpiperidina sustituidos por heterociclos; procedimiento de preparacion; composicion farmaceutica que lo comprende; y uso en el tratamiento del trastorno cardiovasculares, tromboembolicos y tumorales; usos in vitro.
BRPI0813341A2 (pt)	2014-12-23	" uso de compostos, composições curáveis, e, uso de composições curáveis ".
CL2007002207A1 (es)	2008-02-01	Compuestos derivados de sulfonilaminas; composicion farmaceutica; y uso de los compuestos en el tratamiento del glaucoma.
CL2007002920A1 (es)	2008-06-06	Compuestos derivados de 2-aminocarbonilpiridina; composicion farmaceutica; y uso para el tratamiento de trastornos vasculares oclusivos.
WO2006116221A3 (en)	2007-04-12	Therapeutic combinations for the treatment or prevention of psychotic disorders
BR0318278A (pt)	2006-05-23	compostos de éter aminocicloexìlico e usos dos mesmo
CR10305A (es)	2009-02-19	"derivados sustituidos de cromanol y su uso.
BRPI0717369A2 (pt)	2014-10-07	Composto, medicamento, composição farmacêutica que o contém e uso do composto.
CL2007003643A1 (es)	2008-03-24	Composicion farmaceutica de azimilidina que comprende 0,5% a aproximadamente 2,5% (w/w) de agua; y uso para el tratamiento de arritmias cardiacas.
BR0313220A (pt)	2005-06-14	Pelìcula de revestimento para comprimidos e cápsulas
EP2376549A4 (en)	2012-11-14	HIGHLY pure IONOMERIC MIXTURES AND ARTICLES THEREWITH